Lv4
450 积分 2023-08-30 加入
LOX-1 in Atherosclerosis and Myocardial Ischemia
2小时前
已完结
The LRRK2 G2019S mutation in a series of Argentinean patients with Parkinson's disease: Clinical and demographic characteristics
15天前
已完结
Microglial LOX-1 reacts with extracellular HSP60 to bridge neuroinflammation and neurotoxicity
23天前
已完结
Microglial LOX-1/MAPKs/NF-κB positive loop promotes the vicious cycle of neuroinflammation and neural injury
23天前
已完结
Targeting NLRP3 inflammasome for neurodegenerative disorders
2个月前
已完结
Pyroptosis in inflammatory diseases and cancer
2个月前
已完结
Leucine-rich repeat kinase-2 (LRRK2) modulates microglial phenotype and dopaminergic neurodegeneration
2个月前
已完结
LRRK2 in Parkinson disease: challenges of clinical trials
2个月前
已完结
Loss of primary cilia and dopaminergic neuroprotection in pathogenic LRRK2-driven and idiopathic Parkinson’s disease
2个月前
已完结
Aging and Parkinson's Disease: Inflammaging, neuroinflammation and biological remodeling as key factors in pathogenesis
2个月前
已完结
皖公网安备34019202002308
